WHO MAKES THE DIABETES DRUG COPYRIGHT NO FURTHER A MYSTERY

San Diego-primarily based Viking Therapeutics marked alone as a serious competitor in the weight loss drug industry in February following revealing promising data from a mid-phase trial of experimental drug VK2735, which instructed it rivaled—and outperformed—Novo and Lilly drugs when provided like a weekly injection and in March the company un